TXG insider trading — 10x Genomics, Inc.
Over the last 90 days, insiders at 10x Genomics, Inc. (TXG) made 0 open-market purchases worth $0 and 5 open-market sales worth $5.51M, making them net sellers by $5.51M. The largest sale was by Stuelpnagel John R (Director), who sold 20,000 shares for $1.24M on Sep 3, 2026.
Updated Oct 16, 2026.
Recent TXG insider transactions
Every Form 4 filed by 10x Genomics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Suliman Shehnaaz | Director | S · Sale · 10b5-1 | Direct | 5,723 | $81.19 | $465K | Form 4 |
| Sep 22, 2026 | Saxonov Serge | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 25,000 | $81.22 | $2.03M | Form 4 |
| Sep 9, 2026 | Taich Adam | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 46,388 | $64.57 | $3.00M | Form 4 |
| Sep 3, 2026 | Stuelpnagel John R | Director | S · Sale | Direct | 20,000 | $61.75 | $1.24M | Form 4 |
| Sep 1, 2026 | Saxonov Serge | Chief Executive Officer | G · Gift | Direct | 100 | — | — | Form 4 |
| Aug 26, 2026 | Saxonov Serge | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 10,486 | $63.69 | $668K | Form 4 |
| Aug 24, 2026 | Saxonov Serge | Chief Executive Officer | S · Sale | Direct | 18,545 | $63.02 | $1.17M | Form 4 |
| Aug 24, 2026 | Taich Adam | Chief Financial Officer | S · Sale | Direct | 17,166 | $63.02 | $1.08M | Form 4 |
| Aug 24, 2026 | Hindson Benjamin J. | See Remarks | S · Sale | Direct | 13,818 | $63.02 | $871K | Form 4 |
| Aug 24, 2026 | Suliman Shehnaaz | Director | S · Sale · 10b5-1 | Direct | 2,207 | $63.65 | $140K | Form 4 |
| Aug 20, 2026 | Saxonov Serge | Chief Executive Officer | G · Gift | Direct | 4,000 | — | — | Form 4 |
| Aug 14, 2026 | Teichmann Sarah A. | Director | S · Sale · 10b5-1 | Direct | 2,273 | $57.15 | $130K | Form 4 |
| Aug 13, 2026 | Teichmann Sarah A. | Director | S · Sale · 10b5-1 | Direct | 5,278 | $57.29 | $302K | Form 4 |
| Aug 11, 2026 | Stuelpnagel John R | Director | S · Sale | Direct | 20,000 | $57.75 | $1.16M | Form 4 |
TXG insider trading FAQ
Are insiders buying TXG stock?
Not on the open market. In the last 90 days, 10x Genomics, Inc. insiders made no open-market purchases, and 5 open-market sales totaling $5.51M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading TXG?
Recent sellers: Hindson Benjamin J., Saxonov Serge, Stuelpnagel John R, Taich Adam.
Where does TXG insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.